Modeling the Cost-Utility of Treatment Sequences for Multiple Sclerosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modeling the Cost-Utility of Treatment Sequences for Multiple Sclerosis
Authors
Keywords
disease modifying treatment, microsimulation, network meta-analysis, societal perspective, treatment sequence
Journal
VALUE IN HEALTH
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-08-11
DOI
10.1016/j.jval.2021.05.020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The influence of age at disease onset on future relapses and disability progression in multiple sclerosis patients on immunomodulatory treatment
- (2020) Viktor von Wyl et al. EUROPEAN JOURNAL OF NEUROLOGY
- A Multidimensional Array Representation of State-Transition Model Dynamics
- (2020) Eline M. Krijkamp et al. MEDICAL DECISION MAKING
- Desirability and acceptability of a treatment-sequencing model in relapsing-remitting multiple sclerosis: A health technology assessment perspective
- (2020) Marjanne A. Piena et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Severity-Adjusted Probability of Being Cost Effective
- (2019) Matthijs M. Versteegh et al. PHARMACOECONOMICS
- Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands
- (2019) Renée Else Michels et al. Applied Health Economics and Health Policy
- A Dutch validation study of the Multiple Sclerosis Work Difficulties Questionnaire in relapsing remitting multiple sclerosis
- (2019) Elianne van Egmond et al. DISABILITY AND REHABILITATION
- Microsimulation Modeling for Health Decision Sciences Using R: A Tutorial
- (2018) Eline M. Krijkamp et al. MEDICAL DECISION MAKING
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
- (2018) Xavier Montalban et al. Multiple Sclerosis Journal
- Modeling Approaches in Cost-Effectiveness Analysis of Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis: An Updated Systematic Review and Recommendations for Future Economic Evaluations
- (2018) Luis Hernandez et al. PHARMACOECONOMICS
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
- (2018) Xavier Montalban et al. Multiple Sclerosis Journal
- Disease-Modifying Therapies for Relapsing–Remitting and Primary Progressive Multiple Sclerosis: A Cost-Utility Analysis
- (2018) Marita Zimmermann et al. CNS DRUGS
- An Overview of R in Health Decision Sciences
- (2017) Hawre Jalal et al. MEDICAL DECISION MAKING
- New insights into the burden and costs of multiple sclerosis in Europe: Results for the Netherlands
- (2017) Bernard Uitdehaag et al. Multiple Sclerosis Journal
- Update of the Dutch manual for costing studies in health care
- (2017) Tim A. Kanters et al. PLoS One
- New insights into the burden and costs of multiple sclerosis in Europe: Results for the Netherlands
- (2017) Bernard Uitdehaag et al. Multiple Sclerosis Journal
- Convergence yet Continued Complexity: A Systematic Review and Critique of Health Economic Models of Relapsing-Remitting Multiple Sclerosis in the United Kingdom
- (2015) Felicity Allen et al. VALUE IN HEALTH
- Impact of multiple sclerosis relapse: The NARCOMS participant perspective
- (2015) Molly Nickerson et al. Multiple Sclerosis and Related Disorders
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
- (2013) D. Husereau et al. BMJ-British Medical Journal
- Incidence of Multiple Sclerosis in the General Population in the Netherlands, 19962008
- (2012) M.A. Kramer et al. NEUROEPIDEMIOLOGY
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Condition-Specific Preference-Based Measures: Benefit or Burden?
- (2012) Matthijs M. Versteegh et al. VALUE IN HEALTH
- The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
- (2010) Antonio Scalfari et al. BRAIN
- A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
- (2010) Gavin Giovannoni et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More